Luca Benatti Net Worth & Insider Trades
Luca Benatti - Director, Intercept Pharmaceuticals, Inc
What is Luca Benatti's Net Worth?
The current estimated net worth of Intercept Pharmaceuticals, Inc's Director, Luca Benatti, is estimated to be about $169.28K . Luca Benatti owns about 7,556 units of Intercept Pharmaceuticals, Inc common stock. In the last 9 years at Intercept Pharmaceuticals, Inc, Luca Benatti has sold an estimated value of $0 worth.
What is Luca Benatti's Past Insider Trading?
Luca Benatti's largest purchase order was 800 units , worth over $111.89K on December 15, 2014. In total, Luca Benatti has made about 11 transactions over 9 years of their time at Intercept Pharmaceuticals, Inc. Luca Benatti usually trades in June, with the busiest year in 2019. The most recent transaction was a purchase order of 1,200 units , worth over $100.2K on May 14, 2019.
Luca Benatti
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Luca Benatti's' Mailing Address?
- Mailing address is C/o Intercept Pharmaceuticals, Inc. 450 West 15th Street, Suite 505 New York NY 10011 NY
Intercept Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Pruzanski, M.D., | 2020 | $757,850 | - | $4,113,504 | $1,015,996 | $531,995 | $7,660 | $6,427,005 |
| Mark Pruzanski, M.D., | 2019 | $734,292 | - | $4,197,742 | $1,116,118 | $560,265 | $7,368 | $6,615,785 |
| Mark Pruzanski, M.D., | 2018 | $702,000 | - | $1,667,718 | $1,705,358 | $442,260 | $8,623 | $4,525,960 |
| Jerome Durso, | 2020 | $599,524 | - | $2,057,016 | $998,776 | $231,737 | $21,910 | $3,908,963 |
| Jerome Durso, | 2019 | $573,250 | - | $2,089,570 | $1,238,321 | $359,284 | $21,368 | $4,281,793 |
| Jerome Durso, | 2018 | $540,800 | - | $1,554,326 | $775,844 | $292,032 | $22,403 | $3,185,406 |
| Sandip Kapadia, | 2020 | $476,863 | - | $1,087,836 | $528,088 | $184,039 | $21,910 | $2,298,736 |
| Sandip Kapadia, | 2019 | $464,100 | - | $1,001,664 | $586,573 | $252,935 | $21,368 | $2,326,640 |
| Sandip Kapadia, | 2018 | $442,000 | - | $790,164 | $393,544 | $228,735 | $22,403 | $1,876,846 |
| Richard Kim, | 2020 | $456,095 | - | $1,044,360 | $505,128 | $168,056 | $79,211 | $2,252,850 |
| Richard Kim, | 2019 | $442,900 | $202,800 | $890,368 | $521,398 | $265,519 | $76,343 | $2,399,328 |
| Lisa Bright, | 2020 | $480,552 | - | $925,704 | $453,467 | $240,955 | $139,106 | $2,239,784 |
| Ryan Sullivan, | 2020 | $437,107 | - | $1,087,836 | $528,088 | - | $89,942 | $2,142,973 |
| Ryan Sullivan, | 2019 | $445,520 | - | $1,471,902 | $871,713 | $267,089 | $21,368 | $3,077,592 |
| Ryan Sullivan, | 2018 | $376,158 | - | $1,239,112 | $1,190,351 | $229,122 | $173,437 | $3,208,180 |
| Christian Weyer, M.D., M.A.S., | 2020 | $486,731 | - | $925,704 | $453,467 | $170,804 | $21,910 | $2,058,616 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1270073/000110465921055639/tm218121-2_def14a.htm
What are Intercept Pharmaceuticals, Inc's Past Insider Trades?
Intercept Pharmaceuticals, Inc's most recent insider trade came on March 12, 2021 by Srinivas Akkaraju who bought 237,000 units worth $5.02M . In the last 9 years, insiders at Intercept Pharmaceuticals, Inc have sold an estimated value of $1.66B and bought an estimated value of $148.73M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are David Shapiro, Chief Medical Officer, Mark Pruzanski, Director, and Lisa Bright, President .
INTERCEPT PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||